Mitroflow aortic pericardial bioprosthesis — clinical performance

Objective: Advancing life expectancy with the increased prevalence of aortic valve degenerative disease brings the need for an aortic bioprosthesis with excellent haemodynamic performance and comparable durability. The Mitroflow bioprosthesis has been on the worldwide market, except in the United St...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cardio-thoracic surgery 2009-11, Vol.36 (5), p.818-824
Hauptverfasser:	Jamieson, William Robert Eric, Koerfer, Reiner, Yankah, Charles A., Zittermann, Armin, Hayden, Robert I., Ling, Hilton, Hetzer, Roland, Dolman, William B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Aged, 80 and over Aortic Valve - surgery Aortic valve replacement Biological and medical sciences Bioprosthesis British Columbia - epidemiology Cardiology. Vascular system Epidemiologic Methods Female Germany - epidemiology Heart valve Heart Valve Prosthesis - adverse effects Heart Valve Prosthesis Implantation - adverse effects Heart Valve Prosthesis Implantation - methods Heart Valve Prosthesis Implantation - mortality Humans Male Medical sciences Middle Aged Pericardium - transplantation Pneumology Prosthesis Prosthesis Design Prosthesis Failure Reoperation - statistics & numerical data Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!